What does APOTHEEK LUC VANDEPITTE do?

APOTHEEK LUC VANDEPITTE is a pharmacy in Brugge. Public Limited, started on 27 August 1991, 1 establishment.

What is the address of APOTHEEK LUC VANDEPITTE?

The registered office of APOTHEEK LUC VANDEPITTE is located at Moerkerkse Steenweg 23, 8310 Brugge.

Is APOTHEEK LUC VANDEPITTE still active?

Yes. According to the CBE (1 October 2026) APOTHEEK LUC VANDEPITTE is active, legal situation “Normale toestand”, started on 27 August 1991.

Is APOTHEEK LUC VANDEPITTE registered on Peppol?

Yes, APOTHEEK LUC VANDEPITTE is registered on the Peppol network with ID 0208:0444942859.

What is the enterprise number of APOTHEEK LUC VANDEPITTE?

The enterprise number of APOTHEEK LUC VANDEPITTE is BE0444942859.

When was APOTHEEK LUC VANDEPITTE founded?

APOTHEEK LUC VANDEPITTE was founded on 27 August 1991.

Who are the directors of APOTHEEK LUC VANDEPITTE?

According to the 2024 annual accounts, the directors of APOTHEEK LUC VANDEPITTE are: Luc VANDEPITTE, Sabine COUSSEMENT.

Is APOTHEEK LUC VANDEPITTE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 August 1991; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did APOTHEEK LUC VANDEPITTE make in 2024?

APOTHEEK LUC VANDEPITTE posted a profit after taxes of € 74,846 in financial year 2024.

What is the revenue of APOTHEEK LUC VANDEPITTE?

As a small company, APOTHEEK LUC VANDEPITTE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 143,514.

APOTHEEK LUC VANDEPITTE (Public Limited) - Brugge

Dossier APOTHEEK LUC VANDEPITTE, printed on 1 October 2026 from databakkes.be/en/0444942859/apotheek-luc-vandepitte. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

APOTHEEK LUC VANDEPITTE from Brugge, company number BE0444942859, closed financial year 2024 with a result of € 74,846 after tax. For that financial year APOTHEEK LUC VANDEPITTE recorded a gross margin of € 143,514 and equity of € 282,171. Compared with financial year 2023, the result moved from € -14,074 to € 74,846. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2025.

What it is worth Growing

€ 282,171

▲ 19% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 74,846

▲ still € 14,074 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 135,737

▲ 22% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,623 paid out

41 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Wage cost

€ 17,579

▼ 61% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 32,582

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 46,395

▼ 7% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 40,790

▲ 44% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 102,550 Gross margin 2021: € 102,550 First fiscal year in the series	€ 106,865 Gross margin 2022: € 106,865 ▲ 4% vs 2021 (€ 102,550) Favourable step	€ 42,365 Gross margin 2023: € 42,365 ▼ 60% vs 2022 (€ 106,865) Unfavourable step	€ 143,514 Gross margin 2024: € 143,514 ▲ 239% vs 2023 (€ 42,365) Favourable step	▲ 239%
Profit after taxes	€ 32,745 Profit after taxes 2021: € 32,745 First fiscal year in the series	€ 34,223 Profit after taxes 2022: € 34,223 ▲ 5% vs 2021 (€ 32,745) Favourable step	€ -14,074 Profit after taxes 2023: € -14,074 ▼ € 48,297 vs 2022 (€ 34,223) Unfavourable step	€ 74,846 Profit after taxes 2024: € 74,846 ▲ € 88,920 vs 2023 (€ -14,074) Favourable step	▲ € 88,920
Equity	€ 251,134 Equity 2021: € 251,134 First fiscal year in the series	€ 285,357 Equity 2022: € 285,357 ▲ 14% vs 2021 (€ 251,134) Favourable step	€ 237,949 Equity 2023: € 237,949 ▼ 17% vs 2022 (€ 285,357) Unfavourable step	€ 282,171 Equity 2024: € 282,171 ▲ 19% vs 2023 (€ 237,949) Favourable step	▲ 19%
Total debts	€ 67,086 Total debts 2021: € 67,086 First fiscal year in the series	€ 88,952 Total debts 2022: € 88,952 ▲ 33% vs 2021 (€ 67,086) Unfavourable step	€ 86,185 Total debts 2023: € 86,185 ▼ 3% vs 2022 (€ 88,952) Favourable step	€ 100,610 Total debts 2024: € 100,610 ▲ 17% vs 2023 (€ 86,185) Unfavourable step	▲ 17%
Cash	€ 98,475 Cash 2021: € 98,475 First fiscal year in the series	€ 139,487 Cash 2022: € 139,487 ▲ 42% vs 2021 (€ 98,475) Favourable step	€ 110,927 Cash 2023: € 110,927 ▼ 20% vs 2022 (€ 139,487) Unfavourable step	€ 135,737 Cash 2024: € 135,737 ▲ 22% vs 2023 (€ 110,927) Favourable step	▲ 22%
Land & buildings	€ 6,976 Land & buildings 2021: € 6,976 First fiscal year in the series	€ 5,526 Land & buildings 2022: € 5,526 ▼ 21% vs 2021 (€ 6,976) Unchanged	€ 4,076 Land & buildings 2023: € 4,076 ▼ 26% vs 2022 (€ 5,526) Unchanged	€ 4,598 Land & buildings 2024: € 4,598 ▲ 13% vs 2023 (€ 4,076) Unchanged	▲ 13%
Retained profit	€ 189,134 Retained profit 2021: € 189,134 First fiscal year in the series	€ 223,357 Retained profit 2022: € 223,357 ▲ 18% vs 2021 (€ 189,134) Favourable step	€ 175,949 Retained profit 2023: € 175,949 ▼ 21% vs 2022 (€ 223,357) Unfavourable step	€ 220,171 Retained profit 2024: € 220,171 ▲ 25% vs 2023 (€ 175,949) Favourable step	▲ 25%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 33,333 Dividend 2023: € 33,333 Unchanged (€ 0) Unchanged	€ 30,623 Dividend 2024: € 30,623 ▼ 8% vs 2023 (€ 33,333) Unchanged	▼ 8%
Bank debt	€ 1,342 Bank debt 2021: € 1,342 First fiscal year in the series	€ 5,374 Bank debt 2022: € 5,374 ▲ 300% vs 2021 (€ 1,342) Unfavourable step	€ 1,369 Bank debt 2023: € 1,369 ▼ 75% vs 2022 (€ 5,374) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 1,369) Favourable step	▼ 100%
Balance sheet total	€ 318,220 Balance sheet total 2021: € 318,220 First fiscal year in the series	€ 374,309 Balance sheet total 2022: € 374,309 ▲ 18% vs 2021 (€ 318,220) Unchanged	€ 324,134 Balance sheet total 2023: € 324,134 ▼ 13% vs 2022 (€ 374,309) Unchanged	€ 382,781 Balance sheet total 2024: € 382,781 ▲ 18% vs 2023 (€ 324,134) Unchanged	▲ 18%

Key figures of APOTHEEK LUC VANDEPITTE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to APOTHEEK LUC VANDEPITTE?

What happened at APOTHEEK LUC VANDEPITTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Luc VANDEPITTE stepped down as director. NBB
2029 Sabine COUSSEMENT stepped down as director. NBB
Sep 29, 2025 New annual accounts for financial year 2024: profit of € 74,846. filed late Source: NBB ↗
2023 Luc VANDEPITTE became a director. NBB
2023 Sabine COUSSEMENT became a director. NBB
Dec 20, 1991 New establishment in Brugge. KBO
Aug 27, 1991 Start of the company according to the CBE. KBO

In short

From € 32,745 profit in 2021 to € 74,846 profit in 2024.

Paid € 69,895 in corporate taxes since 2021.

Best year ever: 2024, with € 74,846 profit.

Paid out € 63,957 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at APOTHEEK LUC VANDEPITTE? We notify you, reason included.

Follow APOTHEEK LUC VANDEPITTE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Directors

According to the 2024 annual accounts

Luc VANDEPITTE

Managing director

since 2023 · until 2029

Sabine COUSSEMENT

Managing director

since 2023 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Moerkerkse Steenweg 23

8310 Brugge

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0444.942.859

VAT number

BE 0444.942.859

Registered office

Moerkerkse Steenweg 23, 8310 Brugge

Names & denominations

APOTHEEK LUC VANDEPITTE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

27 August 1991

Peppol

Active · Active since 7 Jan 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗